Walleye Capital LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 150 filers reported holding NEKTAR THERAPEUTICS in Q2 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$895,058
-18.0%
1,273,379
+163.7%
0.01%
-35.0%
Q4 2022$1,091,370
-28.0%
482,907
+1.9%
0.02%
-31.0%
Q3 2022$1,516,000
-18.1%
473,751
-2.7%
0.03%
-43.1%
Q2 2022$1,850,000
-8.4%
486,724
+29.9%
0.05%
-5.6%
Q1 2022$2,020,000
+759.6%
374,700
+2765.8%
0.05%
+671.4%
Q3 2021$235,000
-36.0%
13,075
-39.5%
0.01%
-72.0%
Q4 2020$367,000
-69.0%
21,607
-66.8%
0.02%
-64.8%
Q3 2019$1,184,00065,0000.07%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2023
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 1,350,000$22,950,0001.87%
MAVERICK CAPITAL LTD 6,655,625$113,146,0001.81%
Camber Capital Management LP 2,500,000$42,500,0001.49%
Bellevue Group AG 3,866,258$65,726,0000.75%
Adero Partners, LLC 51,500$876,0000.75%
Goodman Financial Corp 108,342$1,842,0000.64%
CM Management, LLC 35,000$595,0000.55%
OSTERWEIS CAPITAL MANAGEMENT INC 424,504$7,217,0000.43%
RICE HALL JAMES & ASSOCIATES, LLC 568,379$9,662,0000.34%
Burleson & Company, LLC 107,736$1,832,0000.32%
View complete list of NEKTAR THERAPEUTICS shareholders